z-logo
open-access-imgOpen Access
Artificial intelligence and machine learning could support drug development for hepatitis A virus internal ribosomal entry sites
Author(s) -
Tatsuo Kanda,
Reina Sasaki,
Ryota Masuzaki,
Mitsuhiko Moriyama
Publication year - 2021
Publication title -
artificial intelligence in gastroenterology
Language(s) - English
Resource type - Journals
ISSN - 2644-3236
DOI - 10.35712/aig.v2.i1.1
Subject(s) - virology , artificial intelligence , computer science , drug development , hepatitis virus , computational biology , drug , hepatitis , biology , pharmacology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom